Replies to post #744963 on NorthWest Biotherapeutics Inc (NWBO)

[XMaster2023]

Boom!

[flipper44]

This is excellent DD Peter Davis provided. This points, imo, far more to a/other company/companies wanting nwbo to pursue this IP expansion for that/those party’s/parties’ particular CI(s). BMY and/or AZN.

[ATLnsider]

This puts Bristol Myers Squibb (BMY) in play, as a potential combination partner, with an already regulatory approved DCVax “complementary agent”.

BMY has the most popular, FDA approved CTLA-4 checkpoint inhibitor on the market now, Ipilimumab (Yervoy).

[learningcurve2020]

Twenty years disciples here posting about these IP patent updates and the stock’s lost 99%+ of its value.